Cytosor

Clinical Trials

Extensive clinical trials have established the efficacy and safety of Cytosorbine in various leukemias and lymphomas. Ongoing studies investigate its use in combination therapies and new indications.

Lab Monitoring

• Complete Blood Count (CBC) with differential, frequently (daily or every other day during induction)
• Liver Function Tests (LFTs)
• Renal Function Tests (RFTs)
• Neurological assessment (especially with high doses)

Doctor Notes

• Careful monitoring of CBC, LFTs, and RFTs is crucial throughout therapy.
• High-dose Cytosorbine requires prophylactic steroid eye drops to prevent conjunctivitis and vigilant neurological monitoring.
• Discuss fertility preservation options with patients of childbearing potential prior to initiation of therapy.

Patient Guidelines

• Report any fever, unusual bleeding or bruising, or signs of infection immediately.
• Stay well-hydrated during treatment.
• Avoid contact with people who have infections.

Missed Dose Advice

As Cytosor is typically administered in a hospital setting under strict medical supervision, a missed dose is unlikely. If a dose is suspected to be missed, contact your healthcare provider immediately for guidance.

Driving Precautions

Cytosor may cause fatigue, dizziness, or visual disturbances. Patients should be advised to avoid driving or operating machinery if they experience these symptoms.

Lifestyle Advice

• Maintain good oral hygiene to prevent stomatitis.
• Avoid raw or undercooked foods to reduce infection risk.
• Get adequate rest.